Physician profile
Robert Lee
NPI 1861897548
$475.28
in general payments reported to CMS, 2019-2025
10 companies · $68.43 in 2025
The $68.43 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $59.00 · 2024: $348 · 2025: $68.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $401 · Honoraria: $15.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $400.58 |
| Honoraria | $15.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| USA Angelalign Technology Corp | $184.05 | 2024 | |
| Sonendo INC | $105.29 | 2024 | Gentlewave G4 Console |
| Colgate Oral Pharmaceuticals, INC. | $59.00 | 2022 | |
| Lightforce Orthodontics, INC. | $22.55 | 2024 | |
| Zimvie INC. | $20.38 | 2025 | |
| Dentsply Sirona INC | $20.26 | 2024 | Tph Spectra Universal Composite Restorative Low Viscosity |
| Solventum Corporation | $17.55 | 2025 | 3m Espe Filtek Supreme Ultra Universal Restorative, Filtek, 3m Scotchbond |
| Benco Dental Supply Co. | $15.70 | 2024 | |
| Elevate Oral Care | $15.42 | 2025 | Fluorimax Mint, Advantage Arrest, Fluorimax 5000 |
| American Orthodontics Corporation | $15.08 | 2025 | Master Series, LP and Ifit Tubes, Radiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.